869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial

BACKGROUND: Intravenous (IV) amphotericin B is the gold standard treatment of severe mycoses. A new orally absorbed, less-toxic formulation of amphotericin has been developed (Matinas Biopharma). We evaluated the efficacy of this novel anti-fungal agent amongst adults with cryptococcal meningitis. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Atukunda, Mucunguzi, Kagimu, Enock, Rutakingirwa, Morris K, Tugume, Lillian, Nsangi, Laura, Musubire, Abdu, Gakuru, Jane, Mugabi, Timothy, Akampurira, Andrew, Ssebambulidde, Kenneth, Kasibante, John, Ellis, Jayne, Mpoza, Edward, Williams, Darlisha A, Fieberg, Ann M, Skipper, Caleb, Abassi, Mahsa, Hullsiek, Kathy Huppler, Meya, David, Boulware, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752325/
http://dx.doi.org/10.1093/ofid/ofac492.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752325/
http://dx.doi.org/10.1093/ofid/ofac492.062

Ejemplares similares